ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983

NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year

December 21, 1973

NLMs Grateful MED Aids Data Searches

March 21, 1986

In Brief: Maryland Wins Center Planning Grant; CRC Receives $5 Million To Endow Chair

December 10, 1999

ACLU Sues Myriad, U.S. Patent Office Over Patents For BRCA Gene Mutations

May 15, 2009